*ES0209.1*
February 17, 2022
ENGROSSED
SENATE BILL No. 209
_____
DIGEST OF SB 209 (Updated February 16, 2022 2:50 pm - DI 131)
Citations Affected: IC 35-31.5; IC 35-48; noncode.
Synopsis: Drug schedules. Adds specified substances to the scheduled
list of controlled substances. Urges the legislative council to assign to
the interim study committee on corrections and criminal code, during
the 2022 legislative interim, the task of studying "delta-8 THC" and any
of its related psychoactive cannabinoids.
Effective: Upon passage; July 1, 2022.
Young M, Brown L
(HOUSE SPONSORS — STEUERWALD, YOUNG J)
January 6, 2022, read first time and referred to Committee on Corrections and Criminal
Law.
January 20, 2022, amended, reported favorably — Do Pass.
January 24, 2022, read second time, amended, ordered engrossed.
January 25, 2022, engrossed. Returned to second reading.
January 27, 2022, re-read second time, amended, ordered engrossed.
January 28, 2022, re-engrossed.
February 1, 2022, read third time, passed. Yeas 36, nays 12.
HOUSE ACTION
February 7, 2022, read first time and referred to Committee on Courts and Criminal Code.
February 17, 2022, amended, reported — Do Pass.
ES 209—LS 6921/DI 92 February 17, 2022
Second Regular Session of the 122nd General Assembly (2022)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2021 Regular Session of the General Assembly.
ENGROSSED
SENATE BILL No. 209
A BILL FOR AN ACT to amend the Indiana Code concerning
criminal law and procedure.
Be it enacted by the General Assembly of the State of Indiana:
1 SECTION 1. IC 35-31.5-2-321, AS AMENDED BY P.L.61-2020,
2 SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
3 JULY 1, 2022]: Sec. 321. "Synthetic drug" means:
4 (1) a substance containing one (1) or more of the following
5 chemical compounds, including an analog of the compound and
6 its isomers, salts, and salts of isomers:
7 (A) JWH-015 ((2-Methyl-1-propyl-1H-
8 indol-3-yl)-1-naphthalenylmethanone).
9 (B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
10 (C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
11 (D) JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone).
12 (E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol-
13 3-yl)methanone).
14 (F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
15 (G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)-
16 naphthalen-1-yl-methanone).
17 (H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
ES 209—LS 6921/DI 92 2
1 (I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
2 (J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
3 (K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl-
4 3-(2-methyloctan-2-yl)-
5 6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).
6 (L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl-
7 3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo
8 [c]chromen-1-ol).
9 (M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-
10 (2-methyloctan- 2-yl)phenyl]-
11 7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
12 (N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6-
13 (1-methylethenyl)-2 -cyclohexen-1-yl]-5
14 -pentyl-2,5-cyclohexadiene-1,4-dione).
15 (O) CP 55,940
16 (2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-
17 5- (2-methyloctan-2-yl)phenol).
18 (P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-
19 (2-methyloctan-2-yl)phenol) and its homologues, or
20 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)
21 phenol), where side chain n=5, and homologues where side
22 chain n=4, 6, or 7.
23 (Q) WIN 55212-2
24 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)
25 pyrrolo [1,2,3-de)- 1,4- benzoxazin-
26 6-yl]-1-napthalenylmethanone).
27 (R) RCS-4 ((4-methoxyphenyl)
28 (1-pentyl-1H-indol-3-yl)methanone).
29 (S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-
30 indol-3-yl)-2-(2-methoxyphenyl)ethanone).
31 (T) 4-Methylmethcathinone. Other name: mephedrone.
32 (U) 3,4-Methylenedioxymethcathinone. Other name:
33 methylone.
34 (V) Fluoromethcathinone.
35 (W) 4-Methoxymethcathinone. Other name: methedrone.
36 (X) 4-Ethylmethcathinone (4-EMC).
37 (Y) Methylenedioxypyrovalerone. Other name: MDPV.
38 (Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.
39 (AA) JWH-098, or
40 1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.
41 (BB) JWH-164, or
42 1-pentyl-3-(7-methoxy-1-naphthoyl)indole.
ES 209—LS 6921/DI 92 3
1 (CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.
2 (DD) JWH-201, or
3 1-pentyl-3-(4-methoxyphenylacetyl)indole.
4 (EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
5 (FF) AM-694, or
6 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
7 (GG) CP 50,556-1, or
8 [(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe
9 ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1
10 -yl] acetate.
11 (HH) Dimethylheptylpyran, or DMHP.
12 (II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.
13 (JJ) 6-APB [6-(2-aminopropyl)benzofuran].
14 (LL) 7-hydroxymitragynine.
15 (MM) á-PPP [á-pyrrolidinopropiophenone].
16 (NN) á-PVP (desmethylpyrovalerone).
17 (OO) AM-251.
18 (PP) AM-1241.
19 (QQ) AM-2201.
20 (RR) AM-2233.
21 (SS) Buphedrone (á-methylamino-butyrophenone (MABP)).
22 (TT) Butylone.
23 (UU) CP-47,497-C7.
24 (VV) CP-47,497-C8.
25 (WW) Desoxypipradol.
26 (XX) Ethylone.
27 (YY) Eutylone.
28 (ZZ) Flephedrone.
29 (AAA) JWH-011.
30 (BBB) JWH-020.
31 (CCC) JWH-022.
32 (DDD) JWH-030.
33 (EEE) JWH-182.
34 (FFF) JWH-302.
35 (GGG) MDAI [5,6-methylenedioxy-2-aminoindane].
36 (HHH) Mitragynine.
37 (III) Naphyrone.
38 (JJJ) Pentedrone.
39 (LLL) Pentylone.
40 (MMM) Methoxetamine
41 [2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].
42 (NNN) A796,260 [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-
ES 209—LS 6921/DI 92 4
1 (2,2,3,3-tetramethylcyclopropyl)methanone].
2 (OOO) AB-001[(1s,3s)-admantan-1-yl)
3 (1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3-
4 (1-adamantoyl)indole].
5 (PPP) AM-356 [Methanandamide].
6 (QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]-
7 1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or
8 [(1-[(N-methylpiperindin-2-yl)
9 Methyl]-3-(Adamant-1-oyl)indole)].
10 (RRR) AM 2233 Azepane isomer [(2-iodophenyl)
11 (1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].
12 (SSS) CB-13 [1-Naphthalenyl
13 [4-(pentyoxy)- 1-naphthalenyl]methanone].
14 (TTT) UR-144 [(1-pentyl-1H-indol-3-yl)
15 (2,2,3,3-tetramethylcyclopropyl)-methanone].
16 (UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-
17 cyclohexylcarbamate].
18 (VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid,
19 cyclohexyl ester].
20 (WWW) URB 754 [6-methyl-2-[(4-methylphenyl)
21 amino]-1-benzoxazin-4-one].
22 (XXX) XLR-11 or 5-fluoro UR-144
23 (1-(5-fluoropentyl)-1H-indol-3-yl)
24 (2,2,3,3-tetramethylcyclopropyl)methanone].
25 (YYY) AKB48 (Other names include:
26 N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide;
27 1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-
28 carboxamide).
29 (ZZZ) 25I-NBOMe (Other names include:
30 4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-
31 benzeneethanamine);
32 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
33 methyl]ethanamine).
34 (AAAA) 2C-C-NBOMe (Other names include: 25C-NBOMe;
35 2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
36 methyl]ethanamine;
37 2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)
38 phenethylamine).
39 (BBBB) 2NE-1 (Other names include: 1-Pentyl-3-
40 (1-adamantylamido)indole).
41 (CCCC) STS-135 (Other names include:
42 N-Adamantyl-1-fluoropentylindole-3- carboxamide
ES 209—LS 6921/DI 92 5
1 (1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-
2 indole-3-carboxamide).
3 (DDDD) PB-22 (Other names include: 1-Pentyl-8-quinolinlyl
4 ester-1H-indole-2-carboxylic acid).
5 (EEEE) 5-Fluoro-PB-22 (Other names include:
6 1-(5-Fluropentyl)-8-quinolinyl ester1H-indole-3-carboxylic
7 acid).
8 (FFFF) Benocyclidine (Other names include: BCP, BTCP, and
9 Benzothiophenylcyclohexylpiperidine).
10 (GGGG) 25B-NBOMe (Other names include: 2C-B-NBOMe
11 and 4-Bromo-2,
12 5-dimenthoxy-N-[(2-Methozyphenyl)methyl]
13 benzeneethanamine).
14 (HHHH) APB (Other names include: (2-Aminopropyl)
15 Benzofuran).
16 (IIII) AB-PINACA
17 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-
18 indazole-3-carboxamide.
19 (JJJJ) AB-FUBINACA
20 (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
21 1H-indazole-3-carboxamide).
22 (KKKK) ADB-PINACA
23 (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
24 indaole-3-carboxamide).
25 (LLLL) Fluoro ADBICA (N-(1-Amino-3,3-
26 dimethyl-1-oxobutan-2-yl)-(fluoropentyl)-1H-indole-3-
27 carboxamide).
28 (MMMM) APDB (Other names include: -EMA,
29 -Desoxy-MDA, and (2-Aminopropyl)-2,3-
30 dihydrobenzofuran).
31 (NNNN) THJ-2201 (Other names include: AM2201 indazole
32 analog, Fluoropentyl-JWH-018 indazole, and
33 5-Fluoro-THJ-018).
34 (OOOO) AM 2201 benzimidazole analog (Other names
35 include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-
36 benzo[d]imidazol-2-yl)(naphthalene-1-yl)methanone).
37 (PPPP) MN-25 (Other names include: 7-methoxy-1-
38 [2-(4-morpholinyl)ethyl]-N-[1S, 2S, 4R)-1,3,3-
39 trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide
40 and UR-12).
41 (QQQQ) FUB-PB-22 (Other names include:
42 Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
ES 209—LS 6921/DI 92 6
1 (RRRR) FUD-PB-22 (Other names include:
2 Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
3 (SSSS) 5-Fluoro-AB-PINACA (Other names include:
4 AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl1-
5 oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
6 carboxaminde).
7 (TTTT) 4-MePPP (Other names include:
8 4-methyl-alpha-pyrrolidinopropiophenone).
9 (UUUU) alpha-PBP (Other names include:
10 Alpha-pyrrolidinobutiophenone).
11 (VVVV) AB-CHMINACA (Other names include:
12 (N-[1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethy
13 l)-1H-indazole-3-carboxamide).
14 (WWWW) Mexedrone
15 (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one).
16 (XXXX) MT-45,
17 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).
18 (YYYY) methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-
19 carboxamido) -3,3-dimethylbutanoate [5F-ADB;
20 5F-MDMB-PINACA].
21 (ZZZZ) methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-
22 carboxamido)-3-methylbutanoate [5F-AMB].
23 (AAAAA) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)
24 -1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide
25 [ADB-FUBINACA].
26 (BBBBB) N-(adamantan-1-yl)-1-(5-fluoropentyl)-
27 1H-indazole-3- carboxamide [5F-APINACA, 5F-AKB48].
28 (CCCCC) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-
29 carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA,
30 MMB-CHMINACA].
31 (DDDDD) methyl 2-(1-(4-fluorobenzyl)-
32 1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate
33 [MDMB-FUBINACA].
34 (EEEEE) N-(1-amino-3,3-dimethyl-1 -oxobutan-2-yl)-1-
35 (cyclohexylmethyl)- 1H-indazole-3-carboxamide
36 [MAB-CHMINACA and ADB-CHMINACA].
37 (FFFFF) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-
38 3-carboxamido)- 3-methylbutanoate [FUB-AMB,
39 MMB-FUBINACA, AMB-FUBINACA].
40 (GGGGG) 3,4-dichloro-N-[(1dimethylamino)cyclohexylme
41 thyl]benzamide) [AH7921].
42 (HHHHH) Naphthalen-1-yl 1-(5-fluoropentyl)-1
ES 209—LS 6921/DI 92 7
1 H-indole-3-carboxylate (trivial name: NM2201; CBL2201)
2 (IIIII) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1
3 H-indazole-3-carboxamide (trivial name:
4 4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINA CA;
5 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78).
6 (JJJJJ) methyl 2-(1-(cyclohexylmethyl)-1
7 H-indole-3-carboxamido)-3-methylbutanoate (trivial names:
8 MMB-CHMICA, AMB-CHMICA).
9 (KKKKK) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1
10 H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name:
11 5F-CUMYL-P7AICA).
12 (LLLLL) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-p
13 entanone (N-ethylpentylone, ephylone).
14 (MMMMM) Synthetic cathinone, 1-(1,3-benzodioxol-5-yl)-2-
15 (ethylamino)- pentan-1-one (N-ethylpentylone, ephylone) and
16 its optical, positional, and geometric isomers, salts, and salts
17 of isomers.
18 (NNNNN) ethyl
19 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
20 dimethylbutanoate (trivial name: 5F-EDMB-PINACA).
21 (OOOOO) methyl 2-(1-(5- fluoropentyl)-1H-indole-3-
22 carboxamido)-3,3-dimethylbutanoate (trivial name:
23 5F-MDMB-PICA).
24 (PPPPP) N- (adamantan- 1-yl)- 1-(4-fluorobenzyl)-
25 1H-indazole-3-carboxamide (trivial names: FUB-AKB48;
26 FUB-APINACA; AKB48 N- (4-FLUOROBENZYL)).
27 (QQQQQ) 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-
28 1H-indazole-3-carboxamide (trivial names:
29 5F-CUMYL-PINACA; SGT-25).
30 (RRRRR) (1-(4-fluorobenzyl)-1H-indol-3-
31 yl)(2,2,3,3-tetramethylcyclopropyl) methanone (trivial name:
32 FUB-144).
33 (SSSSS) 4F-MDMB-BINACA.
34 (TTTTT) N-ethylhexedrone
35 (2-(ethylamino)-1-phenylhexan-1-one).
36 (UUUUU) alpha-pyrrolidinohexanophenone
37 (1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
38 (VVVVV) alpha-pyrrolidinohexiophenone; trivial name:
39 a-PHP.
40 (WWWWW) 4'-methyl-alpha-pyrrolidinohexiophenone
41 (1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
42 (XXXXX) 4-methyl-alphaethylaminopentiophenone
ES 209—LS 6921/DI 92 8
1 (2-(ethylamino)-1-(4-methylphenyl)pentan-1-one; trivial
2 name: 4–MEAP.
3 (YYYYY) 4'-methyl-alphapyrrolidinohexanophenone; trivial
4 name: MPHP.
5 (ZZZZZ) alphapyrrolidinoheptaphenone
6 (1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one; trivial name: PV8.
7 (AAAAAA) 4'-chloro-alphapyrrolidinovalerophenone (1-(4-
8 chlorophenyl)-2-(pyrrolidin-1- yl)pentan-1-one.
9 (BBBBBB) 4'-chloro-alphapyrrolidinopentiophenone; trivial
10 name: 4-chloro-a-PVP.
11 (CCCCCC) 4,4'-dimethylaminorex (common name:
12 4,4'-DMAR).
13 (2) Any compound structurally derived from
14 3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by
15 substitution at the nitrogen atom of the indole ring by alkyl,
16 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
17 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
18 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
19 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
20 or not further substituted in the indole ring to any extent and
21 whether or not substituted in the naphthyl ring to any extent.
22 (3) Any compound structurally derived from 3-(1-naphthoyl)
23 pyrrole by substitution at the nitrogen atom of the pyrrole ring by
24 alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
25 cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
26 2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl,
27 1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl
28 group, whether or not further substituted in the pyrrole ring to any
29 extent and whether or not substituted in the naphthyl ring to any
30 extent.
31 (4) Any compound structurally derived from
32 1-(1-naphthylmethyl)indene by substitution at the 3-position of
33 the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
34 cycloalkylmethyl, cycloalkylethyl,
35 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
36 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
37 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
38 or not further substituted in the indene ring to any extent and
39 whether or not substituted in the naphthyl ring to any extent.
40 (5) Any compound structurally derived from 3-phenylacetylindole
41 by substitution at the nitrogen atom of the indole ring with alkyl,
42 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
ES 209—LS 6921/DI 92 9
1 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
2 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
3 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
4 or not further substituted in the indole ring to any extent and
5 whether or not substituted in the phenyl ring to any extent.
6 (6) Any compound structurally derived from
7 2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position
8 of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
9 cycloalkylmethyl, cycloalkylethyl,
10 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
11 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
12 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
13 or not substituted in the cyclohexyl ring to any extent.
14 (7) Any compound containing a 3-(benzoyl)indole structure with
15 substitution at the nitrogen atom of the indole ring by alkyl,
16 haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
17 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
18 1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
19 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
20 or not further substituted in the indole ring to any extent and
21 whether or not substituted in the phenyl ring to any extent.
22 (8) Any compound, except bupropion or a compound listed under
23 a different schedule, structurally derived from
24 2-aminopropan-1-one by substitution at the 1-position with either
25 phenyl, naphthyl, or thiophene ring systems, whether or not the
26 compound is further modified:
27 (A) by substitution in the ring system to any extent with alkyl,
28 alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
29 substituents, whether or not further substituted in the ring
30 system by one or more other univalent substituents;
31 (B) by substitution at the 3-position with an acyclic alkyl
32 substituent;
33 (C) by substitution at the 2-amino nitrogen atom with alkyl,
34 dialkyl, benzyl, or methoxybenzyl groups; or
35 (D) by inclusion of the 2-amino nitrogen atom in a cyclic
36 structure.
37 (9) Any compound structurally derived from 3-tetramethyl
38 cyclopropanoylindole with substitution at the nitrogen atom of the
39 indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
40 cycloalkylmethyl, cycloalkylethyl,
41 1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl,
42 1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-
ES 209—LS 6921/DI 92 10
1 morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
2 or not further substituted in the indole ring to any extent and
3 whether or not substituted in the tetramethylcyclopropyl ring to
4 any extent.
5 (10) Any compound containing a N-(1-adamantyl)-
6 1H-indazole-3-carboxamide structure with substitution at the
7 nitrogen atom of the indazole ring by an alkyl, haloalkyl,
8 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
9 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
10 1-(N-methyl-2-pyrrolidinyl)methyl,
11 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
12 group, whether or not further substituted at the nitrogen atom of
13 the carboxamide to any extent, whether or not further substituted
14 in the indazole ring to any extent, and whether or not further
15 substituted on the adamantyl ring system to any extent. An
16 example of this structural class includes AKB48.
17 (11) Any compound containing a N-(1-adamantyl)-
18 1H-indole-3-carboxamide structure with substitution at the
19 nitrogen atom of the indole ring by an alkyl, haloalkyl,
20 cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
21 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
22 1-(N-methyl-2-pyrrolidinyl)methyl,
23 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
24 group, whether or not further substituted at the nitrogen atom of
25 the carboxamide to any extent, whether or not further substituted
26 in the indole ring to any extent, and whether or not further
27 substituted on the adamantyl ring system to any extent. An
28 example of this structural class includes STS-135.
29 (12) Any compound containing a 3-(1-adamantoyl)indole
30 structure with substitution at the nitrogen atom of the indole ring
31 by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
32 cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or
33 2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl,
34 1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
35 group, whether or not further substituted on the adamantyl ring
36 system to any extent. An example of this structural class includes
37 AM-1248.
38 (13) Any compound determined to be a synthetic drug by rule
39 adopted under IC 25-26-13-4.1.
40 SECTION 2. IC 35-48-1-17.4, AS ADDED BY P.L.61-2020,
41 SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
42 JULY 1, 2022]: Sec. 17.4. (a) Except as provided in subsections (b)
ES 209—LS 6921/DI 92 11
1 and (c), "isomer" means an optical isomer.
2 (b) "Isomer", as used in IC 35-48-2-4(d), means an optical,
3 positional, or geometric isomer.
4 (c) "Isomer", as used in section 7 of this chapter, means an optical
5 or geometric isomer. "Isomer" means an optical, positional, or
6 geometric isomer.
7 SECTION 3. IC 35-48-2-4, AS AMENDED BY P.L.10-2021,
8 SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
9 JULY 1, 2022]: Sec. 4. (a) The controlled substances listed in this
10 section are included in schedule I.
11 (b) Opiates. Any of the following opiates, including their isomers,
12 esters, ethers, salts, and salts of isomers, esters, and ethers, unless
13 specifically excepted by rule of the board or unless listed in another
14 schedule, whenever the existence of these isomers, esters, ethers, and
15 salts is possible within the specific chemical designation:
16 4-fluoroisobutyryl fentanyl
17 Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-
18 piperidinyl]-N-phenylacetamide) (9815)
19 Acetyl fentanyl (Other names include:
20 N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide)
21 Acetylmethadol (9601)
22 Acrylfentanyl. Other name: N-(1-phenethylpiperidin-4-yl)-
23 N-phenylacrylamide
24 Allylprodine (9602)
25 Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
26 thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide) (9832)
27 Alphacetylmethadol (9603)
28 Alphameprodine (9604)
29 Alphamethadol (9605)
30 Alphamethylfentanyl (9814)
31 Benzethidine (9606)
32 Beta-hydroxy-3-methylfentanyl (9831). Other name:
33 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl
34 ]-N-phenylpropanamide
35 Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
36 phenethyl)-4-piperidinyl]-N-phenylpropanamide) (9830)
37 Betacetylmethadol (9607)
38 Betameprodine (9608)
39 Betamethadol (9609)
40 Betaprodine (9611)
41 Brorphine
42 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1yl)-N,N-di
ES 209—LS 6921/DI 92 12
1 ethylethan-1-amine (butonitazene)
2 Clonitazene (9612)
3 Cyclopentyl fentanyl. Other name:
4 N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide
5 Dextromoramide (9613)
6 Diampromide (9615)
7 Diethylthiambutene (9616)
8 N,N-diethyl-2-(2-(4-flourobenzyl)-5-nitro-1H-benzimidazol-
9 1-yl)ethan-1-amine (flunitazene)
10 N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)e
11 than-1-amine (metodesnitazene)
12 N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidaz
13 ol-1-yl)ethan-1-amine (metonitazene)
14 N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidaz
15 ol-1-yl)ethan-1-amine (protonitazene)
16 Difenoxin (9168)
17 Dimenoxadol (9617)
18 Dimepheptanol (9618)
19 Dimethylthiambutene (9619)
20 Dioxaphetyl butyrate (9621)
21 Dipipanone (9622)
22 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1yl)-N,N-diethyleth
23 an-1-amine (etodesnitazene; etazene)
24 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-
25 benzimidazole (N-pyrrolidino etonitazene; etonitazepyne)
26 Ethylmethylthiambutene (9623)
27 Etonitazene (9624)
28 Etoxeridine (9625)
29 Fentanyl related substances.
30 Furanyl fentanyl.
31 Furethidine (9626)
32 Hydroxypethidine (9627)
33 Isobutyryl fentanyl. Other name:
34 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide
35 Isotonitazene. Other name: N,N-diethyl-2-
36 (2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-
37 1-yl)ethan-1-amine)
38 Ketobemidone (9628)
39 Levomoramide (9629)
40 Levophenacylmorphan (9631)
41 Methoxyacetyl fentanyl. Other name:
42 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide
ES 209—LS 6921/DI 92 13
1 3-Methylfentanyl [N-[3-methyl-1-(2-phenylethyl)-4-
2 piperidyl]-N-phenyl-propanimide](9813)
3 3-Methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-
4 piperidinyl]-N-phenylpropanamide) (9833)
5 MDMB-4en-PINACA
6 4F-MDMB-BICA; 4-fluoro MDMB-BICA; 4F-MDMB-BUTICA;
7 Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,
8 3-dimethyl-butanoate
9 MPPP (1-methyl-4-phenyl-4-propionoxypiperidine) (9961)
10 Morpheridine (9632)
11 N-[1-benzyl-4-piperidyl]-N-phenylpropanamide (benzylfentanyl),
12 including any isomers, salts, or salts of isomers (9818)
13 N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl] 25 piperidin-4-yl]-
14 N-phenylpropionamide, also known as N-[1-[2-hydroxy-2-
15 (2-thienyl)ethyl] -4- piperidinyl]- N-phenylpropanamide,
16 (beta-hydroxythiofentanyl)
17 N-(4-chlorophenyl)- N-(1-phenethylpiperidin-4-yl) isobutyramide
18 (para-chloroisobutyryl fentanyl)
19 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
20 acetamide (ocfentanil)
21 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4 -yl) butyramide
22 (para-fluorobutyryl fentanyl)
23 N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, also known
24 as N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide, (butyryl
25 fentanyl)
26 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide (valeryl
27 fentanyl)
28 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin -4-yl) butyramide
29 (para-methoxybutyryl fentanyl)
30 N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide
31 (thenylfentanyl), including any isomers, salts, or salts of isomers
32 (9834)
33 N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide (isobutyryl
34 fentanyl)
35 N-(1-phenethylpiperidin-4-yl)- Nphenylcyclopentanecarboxamide
36 (cyclopentyl fentanyl)
37 Noracymethadol (9633)
38 Norlevorphanol (9634)
39 Normethadone (9635)
40 Norpipanone (9636)
41 Ocfentanil. Other name:
42 N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)
ES 209—LS 6921/DI 92 14
1 acetamide
2 Ortho-fluorofentanyl or 2-fluorofentanyl. Other name:
3 N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide
4 Para-chloroisobutyryl fentanyl. Other name:
5 N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide
6 Para-fluorobutyryl fentanyl. Other name:
7 N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
8 Para-fluorofentanyl (N-(4-fluorophenyl)-N-
9 [1-(2-phenethyl)-4-piperidinyl] propanamide (9812)
10 Para-methoxybutyryl fentanyl. Other name:
11 N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide
12 Phenadoxone (9637)
13 Phenampromide (9638)
14 Phenomorphan (9647)
15 Phenoperidine (9641)
16 PEPAP [1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine] (9663)
17 Piritramide (9642)
18 Proheptazine (9643)
19 Properidine (9644)
20 Propiram (9649)
21 Racemoramide (9645)
22 Tetrahydrofuranyl fentanyl. Other name:
23 N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carb
24 oxamide
25 Thiofentanyl (N-phenyl-N-[ 1-(2-thienyl)ethyl-4-
26 piperidinyl]-propanamide) (9835)
27 Tilidine (9750)
28 Trimeperidine (9646)
29 U47700 (3,4-dichloro- N- [2-dimethylamino)cyclohexyl]-
30 N-methyl- benzamide)
31 Valeryl fentanyl. Other name:
32 N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide
33 (c) Opium derivatives. Any of the following opium derivatives, their
34 salts, isomers, and salts of isomers, unless specifically excepted by rule
35 of the board or unless listed in another schedule, whenever the
36 existence of these salts, isomers, and salts of isomers is possible within
37 the specific chemical designation:
38 Acetorphine (9319)
39 Acetyldihydrocodeine (9051)
40 Benzylmorphine (9052)
41 Codeine methylbromide (9070)
42 Codeine-N-Oxide (9053)
ES 209—LS 6921/DI 92 15
1 Cyprenorphine (9054)
2 Desomorphine (9055)
3 Dihydromorphine (9145)
4 Drotebanol (9335)
5 Etorphine (except hydrochloride salt) (9056)
6 Heroin (9200)
7 Hydromorphinol (9301)
8 Methyldesorphine (9302)
9 Methyldihydromorphine (9304)
10 Morphine methylbromide (9305)
11 Morphine methylsulfonate (9306)
12 Morphine-N-Oxide (9307)
13 Myrophine (9308)
14 Nicocodeine (9309)
15 Nicomorphine (9312)
16 Normorphine (9313)
17 Pholcodine (9314)
18 Thebacon (9315)
19 (d) Hallucinogenic substances. Unless specifically excepted or
20 unless listed in another schedule, any material, compound, mixture, or
21 preparation which contains any quantity of the following
22 hallucinogenic, psychedelic, or psychogenic substances, their salts,
23 isomers, and salts of isomers whenever the existence of these salts,
24 isomers, and salts of isomers is possible within the specific chemical
25 designation (for purposes of this subsection only, the term "isomer"
26 includes the optical, position, and geometric isomers): designation:
27 (1) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine (7473). Other name:
28 TCPy.
29 (2) 4-Bromo-2, 5-Dimethoxyamphetamine (7391). Some trade or
30 other names: 4-Bromo-2, 5-Dimethoxy-a-methylphenethylamine;
31 4-Bromo-2, 5-DMA.
32 (3) 4-Bromo-2, 5-dimethoxyphenethylamine (7392). Some trade
33 or other names:
34 2-[4-bromo-2,5-dimethoxyphenyl]-1-aminoethane;
35 alpha-desmethyl DOB; 2C-B, Nexus.
36 (4) 2, 5-Dimethoxy-4-ethylamphet-amine (7399). Other name:
37 DOET.
38 (5) 2, 5-Dimethoxy-4-(n)-propylthiophenethylamine (7348).
39 Other name: 2C-T-7.
40 (6) 2, 5-Dimethoxyamphetamine (7396). Some trade or other
41 names: 2, 5-Dimethoxy-a-methylphenethylamine; 2, 5-DMA.
42 (7) 4-Methoxyamphetamine (7411). Some trade or other names:
ES 209—LS 6921/DI 92 16
1 4-Methoxy-a-methylphenethylamine; Paramethoxyamphetamine;
2 PMA.
3 (8) 5-Methoxy-3, 4-methylenedioxy amphetamine (7401). Other
4 Name: MMDA.
5 (9) 5-Methoxy-N, N-diisopropyltryptamine, including any
6 isomers, salts, or salts of isomers (7439). Other name:
7 5-MeO-DIPT.
8 (10) 4-methyl-2, 5-dimethoxyamphetamine (7395). Some trade
9 and other names: 4-methyl-2,
10 5-dimethoxy-a-methylphenethylamine; DOM; and STP.
11 (11) 3, 4-methylenedioxy amphetamine (7400). Other name:
12 MDA.
13 (12) 3,4-methylenedioxy-N-ethylamphetamine (7404). Other
14 names: N-ethyl-alpha-methyl-3,4(methylenedioxy)
15 phenethylamine; N-ethyl MDA; MDE; and MDEA.
16 (13) 3, 4-methylenedioxymethamphetamine (MDMA) (7405).
17 (14) 3, 4, 5-trimethoxy amphetamine (7390). Other name: TMA.
18 (15) Alpha-ethyltryptamine (7249). Some trade and other names:
19 Etryptamine; Monase; [alpha]-ethyl-1H-indole-3-ethanamine;
20 3-(2-aminobutyl) indole; [alpha]-ET; and AET.
21 (16) Alpha-methyltryptamine (7432). Other name: AMT.
22 (17) Bufotenine (7433). Some trade and other names:
23 3-(B-Dimethylaminoethyl)-5-hydroxyindole;
24 3-(2-dimethylaminonethyl)-5-indolol; N, N-dimethylserotonin;
25 5-hydroxy-N, N-dimethyltryptamine; mappine.
26 (18) Diethyltryptamine (7434). Some trade or other names: N,
27 N-Diethyltryptamine; DET.
28 (19) Dimethyltryptamine (7435). Some trade or other names:
29 DMT.
30 (20) Ibogaine (7260). Some trade and other names: 7-Ethyl-6, 6b,
31 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-pyrido
32 (1', 2': 1, 2, azepino 4, 5-b) indole; tabernanthe iboga.
33 (21) Lysergic acid diethylamide (7315). Other name: LSD.
34 (22) Marijuana (7360).
35 (23) Mescaline (7381).
36 (24) Parahexyl (7374). Some trade or other names:
37 3-Hexyl-1-hydroxy-7, 8, 9, 10-Tetrahydro-6, 6,
38 9-trimethyl-6H-dibenzo (b,d) pyran; Snyhexyl.
39 (25) Peyote (7415), including:
40 (A) all parts of the plant that are classified botanically as
41 lophophora williamsii lemaire, whether growing or not;
42 (B) the seeds thereof;
ES 209—LS 6921/DI 92 17
1 (C) any extract from any part of the plant; and
2 (D) every compound, manufacture, salt, derivative, mixture, or
3 preparation of the plant, its seeds, or extracts.
4 (26) N-ethyl-3-piperidyl benzilate (7482). Other name: DMZ.
5 (27) N-hydroxy-3,4-methylenedioxyamphetamine (7402). Other
6 names: N-hydroxy-alpha-methyl-3,4
7 (methylenedioxy)phenethylamine; and N-hydroxy MDA.
8 (28) N-methyl-3-piperidyl benzilate (7484). Other name: LBJ.
9 (29) Psilocybin (7437).
10 (30) Psilocyn (7438).
11 (31) Tetrahydrocannabinols (7370), including synthetic
12 equivalents of the substances contained in the plant, or in the
13 resinous extractives of Cannabis, sp. and synthetic substances,
14 derivatives, and their isomers with similar chemical structure and
15 pharmacological activity such as:
16 (A) ð
1
cis or trans tetrahydrocannabinol, and their optical
17 isomers;
18 (B) ð
6
cis or trans tetrahydrocannabinol, and their optical
19 isomers; and
20 (C) ð
3,
4 cis or trans tetrahydrocannabinol, and their optical
21 isomers.
22 Since nomenclature of these substances is not internationally
23 standardized, compounds of these structures, regardless of
24 numerical designation of atomic positions are covered. Other
25 name: THC.
26 (32) Ethylamine analog of phencyclidine (7455). Some trade or
27 other names: N-Ethyl-1-phenylcyclohexylamine;
28 (1-phenylcyclohexyl) ethylamine; N-(1-phenylcyclohexyl)
29 ethylamine; cyclohexamine; PCE.
30 (33) Pyrrolidine analog of phencyclidine (7458). Some trade or
31 other names: 1-(1-phenylcyclohexyl)-pyrrolidine; PCP
y; PHP.
32 (34) Thiophene analog of phencyclidine (7470). Some trade or
33 other names: 1-(1-(2-thienyl) cyclohexyl) piperidine; 2-Thienyl
34 Analog of Phencyclidine; TPCP.
35 (35) Salvia divinorum or salvinorin A, including:
36 (A) all parts of the plant that are classified botanically as salvia
37 divinorum, whether growing or not;
38 (B) the seeds of the plant;
39 (C) any extract from any part of the plant; and
40 (D) every compound, manufacture, salt, derivative, mixture, or
41 preparation of the plant, its seeds, or extracts.
42 (36) 5-Methoxy-N,N-Dimethyltryptamine. Some trade or other
ES 209—LS 6921/DI 92 18
1 names: 5-methoxy-3-[2- (dimethylamino)ethyl]indole;
2 5-MeO-DMT.
3 (37) 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E).
4 (38) 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D).
5 (39) 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C).
6 (40) 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I).
7 (41) 2-[4-(Ethylthio)-2,5-dimethoxyphenyl] ethanamine (2C-T-2).
8 (42) 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl] ethanamine
9 (2C-T-4).
10 (43) 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H).
11 (44) 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N).
12 (45) 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P).
13 (46) Deschloroketamine (2-Phenyl-2-
14 (methylamino)cyclohexanone).
15 (47) 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-
16 ethyltryptamine).
17 (48) N-methyltryptamine (1H-Indole-3-ethanamine, N-methyl-).
18 (e) Depressants. Unless specifically excepted in a rule adopted by
19 the board or unless listed in another schedule, any material, compound,
20 mixture, or preparation which contains any quantity of the following
21 substances having a depressant effect on the central nervous system,
22 including its salts, isomers, and salts of isomers whenever the existence
23 of such salts, isomers, and salts of isomers is possible within the
24 specific chemical designation:
25 Etizolam (4-(2- chlorophenyl)-2- ethyl-9- methyl- 6H-
26 thieno[3,2-f] [1,2,4] triazolo[4,3-a] [1,4diazepine) (other names
27 include: Etilaam, Etizest, Depas, Etizola, Sedekopan, and
28 Pasaden)
29 Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-
30 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)
31 Gamma-hydroxybutyric acid (other names include GHB;
32 gamma-hydroxybutyrate; 4-hydroxybutanoic acid; sodium
33 oxybate; sodium oxybutyrate) (2010)
34 Mecloqualone (2572)
35 Methaqualone (2565)
36 (f) Stimulants. Unless specifically excepted or unless listed in
37 another schedule, any material, compound, mixture, or preparation that
38 contains any quantity of the following substances having a stimulant
39 effect on the central nervous system, including its salts, isomers, and
40 salts of isomers:
41 ([+/-]) cis-4-methylaminorex (([+/-])cis-4,5-
42 dihydro-4-methyl-5-phenyl-2-oxazolamine) (1590)
ES 209—LS 6921/DI 92 19
1 Aminorex (1585). Other names: aminoxaphen;
2 2-amino-5-phenyl-2-oxazoline; or
3 4,5-dihydro-5-phenyl-2-oxazolamine.
4 Benzylone, 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan
5 -1-one. Synonyms: BMDP, N-benzyl methylone,
6 3,4-Methylenedioxy-Nbenzylcathinone,
7 N-benzyl-3,4-methylenedioxycathinone.
8 Cathinone (1235). Some trade or other names:
9 2-amino-1-phenyl-1-propanone; alpha-aminopropiophenone;
10 2-aminopropiophenone; and norephedrone.
11 Fenethylline (1503).
12 N-Benzylpiperazine (7493). Other names: BZP; and
13 1-benzylpiperazine.
14 N-ethylamphetamine (1475).
15 Methcathinone (1237). Some other trade names:
16 2-Methylamino-1-Phenylpropan-I-one; Ephedrone;
17 Monomethylpropion; UR 1431.
18 N, N-dimethylamphetamine (1480). Other names: N,
19 N-alpha-trimethyl-benzeneethanamine; and N,
20 N-alpha-trimethylphenethylamine.
21 (g) Synthetic drugs as defined in IC 35-31.5-2-321.
22 SECTION 4. [EFFECTIVE UPON PASSAGE] (a) The legislative
23 council is urged to assign to the interim study committee on
24 corrections and criminal code, during the 2022 legislative interim,
25 the task of studying "delta-8 THC" and any of its related
26 psychoactive cannabinoids.
27 (b) This SECTION expires January 1, 2023.
28 SECTION 5. An emergency is declared for this act.
ES 209—LS 6921/DI 92 20
COMMITTEE REPORT
Madam President: The Senate Committee on Corrections and
Criminal Law, to which was referred Senate Bill No. 209, has had the
same under consideration and begs leave to report the same back to the
Senate with the recommendation that said bill be AMENDED as
follows:
Page 1, between the enacting clause and line 1, begin a new
paragraph and insert:
"SECTION 1. IC 35-31.5-2-321, AS AMENDED BY P.L.61-2020,
SECTION 2, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 321. "Synthetic drug" means:
(1) a substance containing one (1) or more of the following
chemical compounds, including an analog of the compound:
(A) JWH-015 ((2-Methyl-1-propyl-1H-
indol-3-yl)-1-naphthalenylmethanone).
(B) JWH-018 (1-pentyl-3-(1-naphthoyl)indole).
(C) JWH-019 (1-hexyl-3-(naphthalen-1-oyl)indole).
(D) JWH-073 (naphthalen-1-yl-(1-butylindol-3-yl)methanone).
(E) JWH-081 (4-methoxynaphthalen- 1-yl- (1-pentylindol-
3-yl)methanone).
(F) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
(G) JWH-200 ((1-(2-morpholin-4-ylethyl)indol-3-yl)-
naphthalen-1-yl-methanone).
(H) JWH-250 (1-pentyl-3-(2-methoxyphenylacetyl)indole).
(I) JWH-251 (1-pentyl-3-(2-methylphenylacetyl)indole).
(J) JWH-398 (1-pentyl-3-(4-chloro-1-naphthoyl)indole).
(K) HU-210 ((6aR,10aR)- 9-(Hydroxymethyl)- 6,6-dimethyl-
3-(2-methyloctan-2-yl)-
6a,7,10,10a-tetrahydrobenzo [c]chromen- 1-ol).
(L) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)- 6,6-dimethyl-
3-(2-methyloctan-2-yl)- 6a,7,10,10a-tetrahydrobenzo
[c]chromen-1-ol).
(M) HU-308 ([(1R,2R,5R)-2-[2,6-dimethoxy-4-
(2-methyloctan- 2-yl)phenyl]-
7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl] methanol).
(N) HU-331 (3-hydroxy-2- [(1R,6R)-3-methyl-6-
(1-methylethenyl)-2 -cyclohexen-1-yl]-5
-pentyl-2,5-cyclohexadiene-1,4-dione).
(O) CP 55,940
(2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl) cyclohexyl]-
5- (2-methyloctan-2-yl)phenol).
ES 209—LS 6921/DI 92 21
(P) CP 47,497 (2-[(1R,3S)-3-hydroxycyclohexyl]- 5-
(2-methyloctan-2-yl)phenol) and its homologues, or
2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)
phenol), where side chain n=5, and homologues where side
chain n=4, 6, or 7.
(Q) WIN 55212-2
((R)-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)
pyrrolo [1,2,3-de)- 1,4- benzoxazin-
6-yl]-1-napthalenylmethanone).
(R) RCS-4 ((4-methoxyphenyl)
(1-pentyl-1H-indol-3-yl)methanone).
(S) RCS-8 (1-(1-(2-cyclohexylethyl)-1H-
indol-3-yl)-2-(2-methoxyphenyl)ethanone).
(T) 4-Methylmethcathinone. Other name: mephedrone.
(U) 3,4-Methylenedioxymethcathinone. Other name:
methylone.
(V) Fluoromethcathinone.
(W) 4-Methoxymethcathinone. Other name: methedrone.
(X) 4-Ethylmethcathinone (4-EMC).
(Y) Methylenedioxypyrovalerone. Other name: MDPV.
(Z) JWH-007, or 1-pentyl-2-methyl-3-(1-naphthoyl)indole.
(AA) JWH-098, or
1-pentyl-2-methyl-3-(4-methoxy-1-naphthoyl)indole.
(BB) JWH-164, or
1-pentyl-3-(7-methoxy-1-naphthoyl)indole.
(CC) JWH-210, or 1-pentyl-3-(4-ethyl-1-naphthoyl)indole.
(DD) JWH-201, or
1-pentyl-3-(4-methoxyphenylacetyl)indole.
(EE) JWH-203, or 1-pentyl-3-(2-chlorophenylacetyl)indole.
(FF) AM-694, or
1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole.
(GG) CP 50,556-1, or
[(6S,6aR,9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpe
ntan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1
-yl] acetate.
(HH) Dimethylheptylpyran, or DMHP.
(II) 4-Methyl-alpha-pyrrolidinobutiophenone, or MPBP.
(JJ) 6-APB [6-(2-aminopropyl)benzofuran].
(LL) 7-hydroxymitragynine.
(MM) á-PPP [á-pyrrolidinopropiophenone].
(NN) á-PVP (desmethylpyrovalerone).
(OO) AM-251.
ES 209—LS 6921/DI 92 22
(PP) AM-1241.
(QQ) AM-2201.
(RR) AM-2233.
(SS) Buphedrone (á-methylamino-butyrophenone (MABP)).
(TT) Butylone.
(UU) CP-47,497-C7.
(VV) CP-47,497-C8.
(WW) Desoxypipradol.
(XX) Ethylone.
(YY) Eutylone.
(ZZ) Flephedrone.
(AAA) JWH-011.
(BBB) JWH-020.
(CCC) JWH-022.
(DDD) JWH-030.
(EEE) JWH-182.
(FFF) JWH-302.
(GGG) MDAI [5,6-methylenedioxy-2-aminoindane].
(HHH) Mitragynine.
(III) Naphyrone.
(JJJ) Pentedrone.
(LLL) Pentylone.
(MMM) Methoxetamine
[2-(3-methoxyphenyl)-2-(ethylamino)- cyclohexanone].
(NNN) A796,260 [1-(2-morpholin-4-ylethyl)-1H-indol-3-yl]-
(2,2,3,3-tetramethylcyclopropyl)methanone].
(OOO) AB-001[(1s,3s)-admantan-1-yl)
(1-pentyl-1H-indol-3-yl)methanone] or [1-Pentyl-3-
(1-adamantoyl)indole].
(PPP) AM-356 [Methanandamide].
(QQQ) AM 1248 [1-[(1-methyl-2- piperidinyl) methyl]-
1H-indol-3-yl] tricyclo[3.3.1.13,7] dec-1-yl-methanone]or
[(1-[(N-methylpiperindin-2-yl)
Methyl]-3-(Adamant-1-oyl)indole)].
(RRR) AM 2233 Azepane isomer [(2-iodophenyl)
(1-(1-methylazepan-3-yl)- 1H-indol-3-yl)methanone].
(SSS) CB-13 [1-Naphthalenyl
[4-(pentyoxy)- 1-naphthalenyl]methanone].
(TTT) UR-144 [(1-pentyl-1H-indol-3-yl)
(2,2,3,3-tetramethylcyclopropyl)-methanone].
(UUU) URB 597 [(3'-(aminocarbonyl) [1,1'-biphenyl]-3-yl)-
cyclohexylcarbamate].
ES 209—LS 6921/DI 92 23
(VVV) URB602 [[1,1'-biphenyl]- 3-yl-carbamic acid,
cyclohexyl ester].
(WWW) URB 754 [6-methyl-2-[(4-methylphenyl)
amino]-1-benzoxazin-4-one].
(XXX) XLR-11 or 5-fluoro UR-144
(1-(5-fluoropentyl)-1H-indol-3-yl)
(2,2,3,3-tetramethylcyclopropyl)methanone].
(YYY) AKB48 (Other names include:
N-Adamantyl-1-pentyl-1H-Indazole-3-carboxamide;
1-pentyl-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-indazole-3-
carboxamide).
(ZZZ) 25I-NBOMe (Other names include:
4-Iodo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-
benzeneethanamine);
2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
methyl]ethanamine).
(AAAA) 2C-C-NBOMe (Other names include: 25C-NBOMe;
2-(4-chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)
methyl]ethanamine;
2,5-Dimethoxy-4-chloro-N-(2-methoxybenzyl)
phenethylamine).
(BBBB) 2NE-1 (Other names include: 1-Pentyl-3-
(1-adamantylamido)indole).
(CCCC) STS-135 (Other names include:
N-Adamantyl-1-fluoropentylindole-3- carboxamide
(1-5-fluoropentyl)-N-tricyclo[3.3.1.13.7]dec-1-yl-1H-
indole-3-carboxamide).
(DDDD) PB-22 (Other names include: 1-Pentyl-8-quinolinlyl
ester-1H-indole-2-carboxylic acid).
(EEEE) 5-Fluoro-PB-22 (Other names include:
1-(5-Fluropentyl)-8-quinolinyl ester1H-indole-3-carboxylic
acid).
(FFFF) Benocyclidine (Other names include: BCP, BTCP, and
Benzothiophenylcyclohexylpiperidine).
(GGGG) 25B-NBOMe (Other names include: 2C-B-NBOMe
and 4-Bromo-2,
5-dimenthoxy-N-[(2-Methozyphenyl)methyl]
benzeneethanamine).
(HHHH) APB (Other names include: (2-Aminopropyl)
Benzofuran).
(IIII) AB-PINACA
(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-
ES 209—LS 6921/DI 92 24
indazole-3-carboxamide.
(JJJJ) AB-FUBINACA
(N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide).
(KKKK) ADB-PINACA
(N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-
indaole-3-carboxamide).
(LLLL) Fluoro ADBICA (N-(1-Amino-3,3-
dimethyl-1-oxobutan-2-yl)-(fluoropentyl)-1H-indole-3-
carboxamide).
(MMMM) APDB (Other names include: -EMA,
-Desoxy-MDA, and (2-Aminopropyl)-2,3-
dihydrobenzofuran).
(NNNN) THJ-2201 (Other names include: AM2201 indazole
analog, Fluoropentyl-JWH-018 indazole, and
5-Fluoro-THJ-018).
(OOOO) AM 2201 benzimidazole analog (Other names
include: FUBIMINA, FTHJ, and (1-(5-fluoropentyl)-1H-
benzo[d]imidazol-2-yl)(naphthalene-1-yl)methanone).
(PPPP) MN-25 (Other names include: 7-methoxy-1-
[2-(4-morpholinyl)ethyl]-N-[1S, 2S, 4R)-1,3,3-
trimethylbicyclo[2.2.1]hept-2-yl]-1H-indole-3-carboxamide
and UR-12).
(QQQQ) FUB-PB-22 (Other names include:
Quinolin-8-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
(RRRR) FUD-PB-22 (Other names include:
Naphthalen-1-yl-1-(4-fluorobenzyl)-1H-indole-3-carboxylate).
(SSSS) 5-Fluoro-AB-PINACA (Other names include:
AB-PINACA 5-fluoro analog and N-(1-amino-3-methyl1-
oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-
carboxaminde).
(TTTT) 4-MePPP (Other names include:
4-methyl-alpha-pyrrolidinopropiophenone).
(UUUU) alpha-PBP (Other names include:
Alpha-pyrrolidinobutiophenone).
(VVVV) AB-CHMINACA (Other names include:
(N-[1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethy
l)-1H-indazole-3-carboxamide).
(WWWW) Mexedrone
(3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-one).
(XXXX) MT-45,
(1-cyclohexyl-4-(1,2-diphenylethyl)piperazine).
ES 209—LS 6921/DI 92 25
(YYYY) methyl 2-(1-(5-fluoropentyl)- 1H-indazole-3-
carboxamido) -3,3-dimethylbutanoate [5F-ADB;
5F-MDMB-PINACA].
(ZZZZ) methyl 2-(1-(5-fluoropentyl)-1H- indazole-3-
carboxamido)-3-methylbutanoate [5F-AMB].
(AAAAA) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)
-1-(4-fluorobenzyl)- 1H-indazole-3-carboxamide
[ADB-FUBINACA].
(BBBBB) N-(adamantan-1-yl)-1-(5-fluoropentyl)-
1H-indazole-3- carboxamide [5F-APINACA, 5F-AKB48].
(CCCCC) methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate [MDMB-CHMICA,
MMB-CHMINACA].
(DDDDD) methyl 2-(1-(4-fluorobenzyl)-
1H-indazole-3-carboxamido)- 3,3-dimethylbutanoate
[MDMB-FUBINACA].
(EEEEE) N-(1-amino-3,3-dimethyl-1 -oxobutan-2-yl)-1-
(cyclohexylmethyl)- 1H-indazole-3-carboxamide
[MAB-CHMINACA and ADB-CHMINACA].
(FFFFF) Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-
3-carboxamido)- 3-methylbutanoate [FUB-AMB,
MMB-FUBINACA, AMB-FUBINACA].
(GGGGG) 3,4-dichloro-N-[(1dimethylamino)cyclohexylme
thyl]benzamide) [AH7921].
(HHHHH) Naphthalen-1-yl 1-(5-fluoropentyl)-1
H-indole-3-carboxylate (trivial name: NM2201; CBL2201)
(IIIII) 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1
H-indazole-3-carboxamide (trivial name:
4-CN-CUMYL-BUTINACA; 4-cyano-CUMYL-BUTINA CA;
4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78).
(JJJJJ) methyl 2-(1-(cyclohexylmethyl)-1
H-indole-3-carboxamido)-3-methylbutanoate (trivial names:
MMB-CHMICA, AMB-CHMICA).
(KKKKK) 1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1
H-pyrrolo[2,3-b]pyridine-3-carboxamide (trivial name:
5F-CUMYL-P7AICA).
(LLLLL) N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1-p
entanone (N-ethylpentylone, ephylone).
(MMMMM) Synthetic cathinone, 1-(1,3-benzodioxol-5-yl)-2-
(ethylamino)- pentan-1-one (N-ethylpentylone, ephylone) and
its optical, positional, and geometric isomers, salts, and salts
of isomers.
ES 209—LS 6921/DI 92 26
(NNNNN) ethyl
2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate (trivial name: 5F-EDMB-PINACA).
(OOOOO) methyl 2-(1-(5- fluoropentyl)-1H-indole-3-
carboxamido)-3,3-dimethylbutanoate (trivial name:
5F-MDMB-PICA).
(PPPPP) N- (adamantan- 1-yl)- 1-(4-fluorobenzyl)-
1H-indazole-3-carboxamide (trivial names: FUB-AKB48;
FUB-APINACA; AKB48 N- (4-FLUOROBENZYL)).
(QQQQQ) 1-(5- fluoropentyl)-N-(2-phenylpropan-2-yl)-
1H-indazole-3-carboxamide (trivial names:
5F-CUMYL-PINACA; SGT-25).
(RRRRR) (1-(4-fluorobenzyl)-1H-indol-3-
yl)(2,2,3,3-tetramethylcyclopropyl) methanone (trivial name:
FUB-144).
(SSSSS) 4F-MDMB-BINACA.
(TTTTT) N-ethylhexedrone
(2-(ethylamino)-1-phenylhexan-1-one).
(UUUUU) alpha-pyrrolidinohexanophenone
(1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one.
(VVVVV) alpha-pyrrolidinohexiophenone; trivial name:
a-PHP.
(WWWWW) 4'-methyl-alpha-pyrrolidinohexiophenone
(1-(4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one.
(XXXXX) 4-methyl-alphaethylaminopentiophenone
(2-(ethylamino)-1-(4-methylphenyl)pentan-1-one; trivial
name: 4–MEAP.
(YYYYY) 4'-methyl-alphapyrrolidinohexanophenone; trivial
name: MPHP.
(ZZZZZ) alphapyrrolidinoheptaphenone
(1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one; trivial name: PV8.
(AAAAAA) 4'-chloro-alphapyrrolidinovalerophenone (1-(4-
chlorophenyl)-2-(pyrrolidin-1- yl)pentan-1-one.
(BBBBBB) 4'-chloro-alphapyrrolidinopentiophenone; trivial
name: 4-chloro-a-PVP.
(CCCCCC) 4,4'-dimethylaminorex (common name:
4,4'-DMAR).
(2) Any compound structurally derived from
3-(1-naphthoyl)indole or 1H-indol-3-yl-(1-naphthyl)methane by
substitution at the nitrogen atom of the indole ring by alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
ES 209—LS 6921/DI 92 27
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the naphthyl ring to any extent.
(3) Any compound structurally derived from 3-(1-naphthoyl)
pyrrole by substitution at the nitrogen atom of the pyrrole ring by
alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl,
2-(4-morpholinyl)ethyl, or 1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3- morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted in the pyrrole ring to any
extent and whether or not substituted in the naphthyl ring to any
extent.
(4) Any compound structurally derived from
1-(1-naphthylmethyl)indene by substitution at the 3-position of
the indene ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indene ring to any extent and
whether or not substituted in the naphthyl ring to any extent.
(5) Any compound structurally derived from 3-phenylacetylindole
by substitution at the nitrogen atom of the indole ring with alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the phenyl ring to any extent.
(6) Any compound structurally derived from
2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position
of the phenolic ring by alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not substituted in the cyclohexyl ring to any extent.
(7) Any compound containing a 3-(benzoyl)indole structure with
substitution at the nitrogen atom of the indole ring by alkyl,
haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, or
ES 209—LS 6921/DI 92 28
1-(N-methyl-2-pyrrolidinyl)methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the phenyl ring to any extent.
(8) Any compound, except bupropion or a compound listed under
a different schedule, structurally derived from
2-aminopropan-1-one by substitution at the 1-position with either
phenyl, naphthyl, or thiophene ring systems, whether or not the
compound is further modified:
(A) by substitution in the ring system to any extent with alkyl,
alkylenedioxy, alkoxy, haloalkyl, hydroxyl, or halide
substituents, whether or not further substituted in the ring
system by one or more other univalent substituents;
(B) by substitution at the 3-position with an acyclic alkyl
substituent;
(C) by substitution at the 2-amino nitrogen atom with alkyl,
dialkyl, benzyl, or methoxybenzyl groups; or
(D) by inclusion of the 2-amino nitrogen atom in a cyclic
structure.
(9) Any compound structurally derived from 3-tetramethyl
cyclopropanoylindole with substitution at the nitrogen atom of the
indole ring by an alkyl, haloalkyl, cyanoalkyl, alkenyl,
cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl) ethyl,
1-(N-methyl-2-pyrrolidinyl) methyl, 1-(N-methyl-3-
morpholinyl)methyl, or tetrahydropyranylmethyl group, whether
or not further substituted in the indole ring to any extent and
whether or not substituted in the tetramethylcyclopropyl ring to
any extent.
(10) Any compound containing a N-(1-adamantyl)-
1H-indazole-3-carboxamide structure with substitution at the
nitrogen atom of the indazole ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted at the nitrogen atom of
the carboxamide to any extent, whether or not further substituted
in the indazole ring to any extent, and whether or not further
substituted on the adamantyl ring system to any extent. An
example of this structural class includes AKB48.
(11) Any compound containing a N-(1-adamantyl)-
ES 209—LS 6921/DI 92 29
1H-indole-3-carboxamide structure with substitution at the
nitrogen atom of the indole ring by an alkyl, haloalkyl,
cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl,
1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl,
1-(N-methyl-2-pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted at the nitrogen atom of
the carboxamide to any extent, whether or not further substituted
in the indole ring to any extent, and whether or not further
substituted on the adamantyl ring system to any extent. An
example of this structural class includes STS-135.
(12) Any compound containing a 3-(1-adamantoyl)indole
structure with substitution at the nitrogen atom of the indole ring
by an alkyl, haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl,
cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or
2-(4-morpholinyl)ethyl, 1-(N-methyl-2- pyrrolidinyl)methyl,
1-(N-methyl-3-morpholinyl)methyl, or tetrahydropyranylmethyl
group, whether or not further substituted on the adamantyl ring
system to any extent. An example of this structural class includes
AM-1248.
(13) Any compound determined to be a synthetic drug by rule
adopted under IC 25-26-13-4.1.
SECTION 2. IC 35-48-1-17.4, AS ADDED BY P.L.61-2020,
SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 17.4. (a) Except as provided in subsections (b)
and (c), "isomer" means an optical isomer.
(b) "Isomer", as used in IC 35-48-2-4(d), means an optical,
positional, or geometric isomer.
(c) "Isomer", as used in section 7 of this chapter, means an optical
or geometric isomer. "Isomer" means an optical, positional, or
geometric isomer.".
Page 2, between lines 17 and 18, begin a new line block indented
and insert:
"Brorphine".
Page 2, delete line 42, begin a new line block indented, and insert:
"2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-
benzimidazole (N-pyrrolidino etonitazene; etonitazepyne)".
Page 3, delete line 1.
Page 6, strike line 1.
ES 209—LS 6921/DI 92 30
Page 6, line 2, strike "includes the optical, position, and geometric
isomers):" and insert "designation:".
Renumber all SECTIONS consecutively.
and when so amended that said bill do pass.
(Reference is to SB 209 as introduced.)
YOUNG M, Chairperson
Committee Vote: Yeas 8, Nays 0.
_____
SENATE MOTION
Madam President: I move that Senate Bill 209 be amended to read
as follows:
Page 1, between the enacting clause and line 1, begin a new
paragraph and insert:
"SECTION 1. IC 15-15-13-6.5, AS ADDED BY P.L.190-2019,
SECTION 7, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 6.5. As used in this chapter, "hemp product"
means a product derived from, or made by, processing hemp plants or
plant parts including derivatives, extracts, cannabinoids, isomers, acids,
salts, and salts of isomers. However, the term does not include:
(1) smokable hemp (as defined by IC 35-48-1-26.6); or
(2) products that contain a total delta-9-tetrahydrocannabinol
tetrahydrocannabinol concentration of more than three-tenths
of one percent (0.3%) by weight.
SECTION 2. IC 24-4-21-3, AS AMENDED BY P.L.190-2019,
SECTION 24, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 3. A person may distribute low THC hemp extract
in Indiana only if the distributor has a certificate of analysis prepared
by an independent testing laboratory showing:
(1) that the low THC hemp extract is the product of a batch tested
by the independent testing laboratory;
(2) that the independent testing laboratory determined that the
batch contained not more than three-tenths percent (0.3%) total
delta-9-tetrahydrocannabinol tetrahydrocannabinol (THC),
including precursors and isomers, by weight, based on the testing
of a random sample of the batch; and
(3) the cannabidiol percent present of the low THC hemp extract.
ES 209—LS 6921/DI 92 31
SECTION 3. IC 24-4-21-4, AS ADDED BY P.L.153-2018,
SECTION 9, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 4. (a) Except as provided in subsection (b), low
THC hemp extract must be distributed in packaging that contains the
following information:
(1) A scannable bar code or QR code linked to a document that
contains information with respect to the manufacture of the low
THC hemp extract, including the:
(A) batch identification number;
(B) product name;
(C) batch date;
(D) expiration date, which must be not more than two (2) years
from the date of manufacture;
(E) batch size;
(F) total quantity produced;
(G) ingredients used, including the:
(i) ingredient name;
(ii) name of the company that manufactured the ingredient;
(iii) company or product identification number or code, if
applicable; and
(iv) ingredient lot number; and
(H) download link for a certificate of analysis for the low THC
hemp extract.
(2) The batch number.
(3) The Internet address of a web site to obtain batch information.
(4) The expiration date.
(5) The number of milligrams of low THC hemp extract.
(6) The manufacturer.
(7) The fact that the product contains not more than three-tenths
percent (0.3%) total delta-9-tetrahydrocannabinol
tetrahydrocannabinol (THC), including precursors and isomers,
by weight.
(b) Before July 1, 2018, low THC hemp extract may be distributed
in Indiana without having met the requirements described in subsection
(a).".
Page 1, line 5, delete "compound:" and insert "compound and its
isomers, salts, and salts of isomers:".
Page 11, between lines 5 and 6, begin a new paragraph and insert:
"SECTION 6. IC 35-48-1-17.5, AS AMENDED BY P.L.190-2019,
SECTION 28, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2022]: Sec. 17.5. (a) "Low THC hemp extract" means a
substance or compound that:
ES 209—LS 6921/DI 92 32
(1) is derived from or contains any part of the plant Cannabis
sativa L. that meets the definition of hemp under IC 15-15-13-6;
(2) contains not more than three-tenths percent (0.3%) total
delta-9-tetrahydrocannabinol tetrahydrocannabinol (THC),
including precursors and isomers, by weight; and
(3) contains no other controlled substances.
(b) The term does not include:
(1) the harvested reproductive organ, whether immature or
mature, of the female hemp plant; or
(2) smokable hemp.".
Renumber all SECTIONS consecutively.
(Reference is to SB 209 as printed January 21, 2022.)
BROWN L
_____
SENATE MOTION
Madam President: I move that Engrossed Senate Bill 209, which is
eligible for third reading, be returned to second reading for purposes of
amendment.
YOUNG M
_____
SENATE MOTION
Madam President: I move that Senate Bill 209 be amended to read
as follows:
Page 21, after line 9, begin a new paragraph and insert:
"SECTION 8. IC 35-48-4-18 IS ADDED TO THE INDIANA CODE
AS A NEW SECTION TO READ AS FOLLOWS [EFFECTIVE JULY
1, 2022]: Sec. 18. (a) This section applies to the following offenses:
(1) Dealing in a schedule I, II, or III controlled substance
under section 2 of this chapter.
(2) Possession of a controlled substance under section 7 of this
chapter.
(3) Dealing in marijuana, hash oil, or hashish under section 10
of this chapter.
(4) Possession of marijuana, hash oil, or hashish under section
ES 209—LS 6921/DI 92 33
11 of this chapter.
(b) It is a defense to a prosecution for an offense described in
subsection (a) that all of the following apply:
(1) The controlled substance is hemp (as defined in 7 U.S.C.
1639o(1)). (2) The controlled substance was being shipped
from a licensed producer in another state in continuous
transit through Indiana to a licensed handler in another
state.".
Renumber all SECTIONS consecutively.
(Reference is to SB 209 as reprinted January 25, 2022.)
YOUNG M
_____
COMMITTEE REPORT
Mr. Speaker: Your Committee on Courts and Criminal Code, to
which was referred Senate Bill 209, has had the same under
consideration and begs leave to report the same back to the House with
the recommendation that said bill be amended as follows:
Page 1, delete lines 1 through 17.
Page 2, delete lines 1 through 41.
Page 12, delete lines 23 through 36.
Page 17, line 14, delete "designation:" and insert "designation:".
Page 21, delete lines 10 through 26, begin a new paragraph and
insert:
"SECTION 4. [EFFECTIVE UPON PASSAGE] (a) The legislative
council is urged to assign to the interim study committee on
corrections and criminal code, during the 2022 legislative interim,
the task of studying "delta-8 THC" and any of its related
psychoactive cannabinoids.
(b) This SECTION expires January 1, 2023.
SECTION 5. An emergency is declared for this act.".
Renumber all SECTIONS consecutively.
and when so amended that said bill do pass.
(Reference is to SB 209 as reprinted January 28, 2022.)
MCNAMARA
Committee Vote: yeas 9, nays 0.
ES 209—LS 6921/DI 92